Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Belshe

Showing results (51-60 of 143) with videos related to

Pageof 15
Sort By:
Vaccine|December 2, 1999
Vaccine-induced cytotoxic T lymphocytes against human immunodeficiency virus type 1 using two complementary in vitro stimulation strategiesG J Gorse, G B Patel, M D Mandava, et al.
Clinical and Diagnostic Laboratory Immunology|November 1, 1996
Salivary binding antibodies induced by human immunodeficiency virus type 1 recombinant gp120 vaccine. The NIAID AIDS Vaccine Evaluation GroupG J Gorse, E Y Yang, R B Belshe, et al.
The Journal of Infectious Diseases|December 1, 1984
Live attenuated influenza A virus vaccines in children: results of a field trialR B Belshe, L P Van Voris, J Bartram, et al.
The Journal of Infectious Diseases|September 5, 1998
Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccinationD M Granoff, R K Gupta, R B Belshe, et al.
The West Virginia Medical Journal|March 1, 1981
Epidemiology of severe respiratory syncytial virus infections in Huntington, West VirginiaR B Belshe, L P Van Voris, M A Mufson, et al.
American Journal of Diseases of Children (1960)|November 1, 1973
Cause of acute hemorrhagic cystitis in childrenM A Mufson, R B Belshe, T J Horrigan, et al.
Journal of Clinical Microbiology|October 1, 1992
Detection of binding antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins following recombinant gp160 immunization measured by flow cytometry and enzyme immunoassays. The AIDS Vaccine Clinical Trials NetworkG J Gorse, S E Frey, F K Newman, et al.
Journal of Clinical Microbiology|September 1, 1992
Evaluation of a cold-adapted influenza B/Texas/84 reassortant virus (CRB-87) vaccine in young childrenE L Anderson, F K Newman, H F Maassab, et al.
The Journal of General Virology|April 1, 1994
Role of virion M2 protein in influenza virus uncoating: specific reduction in the rate of membrane fusion between virus and liposomes by amantadineS A Wharton, R B Belshe, J J Skehel, et al.
Journal of Clinical Microbiology|May 1, 1989
Evaluation of cold-recombinant influenza A/Korea (CR-59) virus vaccine in infantsE L Anderson, R B Belshe, B Burk, et al.
Pageof 15

Showing results (51-60 of 143) with videos related to

Sort By:
Pageof 15
Vaccine|December 2, 1999
Vaccine-induced cytotoxic T lymphocytes against human immunodeficiency virus type 1 using two complementary in vitro stimulation strategiesG J Gorse, G B Patel, M D Mandava, et al.
Clinical and Diagnostic Laboratory Immunology|November 1, 1996
Salivary binding antibodies induced by human immunodeficiency virus type 1 recombinant gp120 vaccine. The NIAID AIDS Vaccine Evaluation GroupG J Gorse, E Y Yang, R B Belshe, et al.
The Journal of Infectious Diseases|December 1, 1984
Live attenuated influenza A virus vaccines in children: results of a field trialR B Belshe, L P Van Voris, J Bartram, et al.
The Journal of Infectious Diseases|September 5, 1998
Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccinationD M Granoff, R K Gupta, R B Belshe, et al.
The West Virginia Medical Journal|March 1, 1981
Epidemiology of severe respiratory syncytial virus infections in Huntington, West VirginiaR B Belshe, L P Van Voris, M A Mufson, et al.
American Journal of Diseases of Children (1960)|November 1, 1973
Cause of acute hemorrhagic cystitis in childrenM A Mufson, R B Belshe, T J Horrigan, et al.
Journal of Clinical Microbiology|October 1, 1992
Detection of binding antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins following recombinant gp160 immunization measured by flow cytometry and enzyme immunoassays. The AIDS Vaccine Clinical Trials NetworkG J Gorse, S E Frey, F K Newman, et al.
Journal of Clinical Microbiology|September 1, 1992
Evaluation of a cold-adapted influenza B/Texas/84 reassortant virus (CRB-87) vaccine in young childrenE L Anderson, F K Newman, H F Maassab, et al.
The Journal of General Virology|April 1, 1994
Role of virion M2 protein in influenza virus uncoating: specific reduction in the rate of membrane fusion between virus and liposomes by amantadineS A Wharton, R B Belshe, J J Skehel, et al.
Journal of Clinical Microbiology|May 1, 1989
Evaluation of cold-recombinant influenza A/Korea (CR-59) virus vaccine in infantsE L Anderson, R B Belshe, B Burk, et al.
Pageof 15